A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-75
SponsorUniversity of Nebraska
About this trial
African Americans face racial disparities in colorectal cancer (CRC), with lower screening rates and higher incidence and mortality rates. To address this gap and improve CRC screening rates, investigators aims to recruit a total of 1,200 African American participants aged 45-75 during their visits to the DMV, 4606 N 56th St Ste100, Omaha, for CRC screening. All participants will receive a free Fecal Immunochemical Test (FIT) kit with a prepaid return envelope, a culturally tailored educational brochure, reminder text messages and calls, and post-FIT navigation support for participants with positive results or without family doctor/insurance. Kits are returned to a designated Nebraska Medicine lab for testing, and test results will be mailed to participants within 14-21 days. Participants will be assigned to one of two groups: the on-site distribution group or the on-site distribution group with social media advertising group. The social media advertising group will additionally be exposed to targeted ads on platforms like Facebook, Instagram, and YouTube to increase awareness and potentially improve participation rates. The study will compare FIT kit return rates, positive screening rates, and completion rates of follow-up colonoscopies after positive FIT results between the two groups.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Self-identification as Black or African American
Between 45 and 75 years old
Not up-to-date with colorectal cancer (CRC) screening per guidelines
Willingness to provide contact information for follow-up
Disqualifiers
History of colorectal cancer (CRC)
History of adenomas (precancerous polyps) or inflammatory bowel disease
Family history of colorectal cancer (CRC)
Trial design
Design model
Parallel
Treatments tested in this trial
On-site Fecal Immunochemical Test (FIT) Kit Distribution
Other interventionParticipants will receive home based Fecal Immunochemical Test (FIT) kit directly at the Department of Motor Vehicles (DMV) location at 4606 N 56th St Suite 100, Omaha, NE 68104, by research staff.
On-site With Social Media Advertising Fecal Immunochemical Test (FIT) Kit Distribution
Other interventionParticipants will receive home-based Fecal Immunochemical Test (FIT) kits directly at the Department of Motor Vehicles (DMV) location at 4606 N 56th St Suite 100, Omaha, NE 68104, by research staff supplemented by exposure to targeted social media advertisements.
Treatment groups
1,200 Participants
are divided into 2 treatment groupsGroup A: On-site GroupExperimental treatment 1 intervention
Group B: On-site Group With Social Media AdvertisingActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Fecal Immunochemical Test Kit Return Rate
The fecal immunochemical test kit (FIT) return rate is the proportion of participants who have completed the screening by returning the FIT kits.
Time frame
6 months from date of FIT distributionSecondary outcomes
1
Fecal Immunochemical Test (FIT) Kit Positive Rate
The fecal immunochemical test (FIT) kit positive rate is the proportion of participants who have positive FIT kit results.
Time frame
6 months from date of FIT distribution2
Follow-up Colonoscopy Completion Rate
The follow-up colonoscopy completion rate is the proportion of participants with positive FIT results who complete a follow-up colonoscopy.
Time frame
6 months from date of positive FIT result notificationSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Nebraska
Lead sponsor
Robert Wood Johnson Foundation
Collaborator
Source ClinicalTrials.gov